Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
Titel:
Aztreonam–avibactam versus meropenem for the treatment of serious infections caused by Gram-negative bacteria (REVISIT): a descriptive, multinational, open-label, phase 3, randomised trial
Auteur:
Carmeli, Yehuda Cisneros, José Miguel Paul, Mical Daikos, George L Wang, Minggui Torre-Cisneros, Julian Singer, George Titov, Ivan Gumenchuk, Illia Zhao, Yongjie Jiménez-Rodríguez, Rosa-María Liang, Lu Chen, Gang Pyptiuk, Oleksandr Aksoy, Firdevs Rogers, Halley Wible, Michele Arhin, Francis F Luckey, Alison Leaney, Joanne L Pypstra, Rienk Chow, Joseph W